Evidence map›Paper›PMID 38680765›Full record

ArticleOxford medical case reports2024

Amelanotic melanoma in a kidney transplant patient: a rare case report.

Yara Melhem, Seham Khattab, Moatasem Hussein Al-Janabi, Hussein Saeid, Issa Ahmad, Fouz Hasan

Abstract readCase Reports
In one paragraph

Article in Oxford medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yara MelhemDepartment of Dermatology, Tishreen University Hospital, Lattakia, Syria.
Seham KhattabDepartment of Dermatology, Tishreen University Hospital, Lattakia, Syria.
Moatasem Hussein Al-JanabiDepartment of Pathology, Cancer Research Center, Tishreen University Hospital, Lattakia, Syria.
Hussein SaeidDepartment of Nephrology, Tishreen University Hospital, Lattakia, Syria.
Issa AhmadTishreen University and Al Andulus Private University for Medical Sciences/Faculty of Medicin/Department of Pathology, Tishreen University Hospital, Lattakia, Syria.
Fouz HasanDepartment of Dermatology, Tishreen University Hospital, Lattakia, Syria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosuppressed individuals face a significantly elevated risk of developing aggressive cutaneous malignancies, often surpassing the aggressiveness observed in immunocompetent counterparts. Our patient exhibited several risk factors associated with melanoma development in renal recipients, including skin type, sun exposure, and the duration of immunosuppression. The determination of staging holds paramount importance as it directly influences both prognosis and subsequent management. It is crucial to handle suspected lesions with caution in these patients to facilitate early melanoma detection and enhance overall prognosis.

Identifiers

PMID38680765
PMCPMC11049583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.